MDT

83.87

+0.59%↑

VEEV

220.35

+2.08%↑

A

105.08

+2.22%↑

WBA

10.98

0%↓

CHE

587.63

+1.41%↑

MDT

83.87

+0.59%↑

VEEV

220.35

+2.08%↑

A

105.08

+2.22%↑

WBA

10.98

0%↓

CHE

587.63

+1.41%↑

MDT

83.87

+0.59%↑

VEEV

220.35

+2.08%↑

A

105.08

+2.22%↑

WBA

10.98

0%↓

CHE

587.63

+1.41%↑

MDT

83.87

+0.59%↑

VEEV

220.35

+2.08%↑

A

105.08

+2.22%↑

WBA

10.98

0%↓

CHE

587.63

+1.41%↑

MDT

83.87

+0.59%↑

VEEV

220.35

+2.08%↑

A

105.08

+2.22%↑

WBA

10.98

0%↓

CHE

587.63

+1.41%↑

Search

Minerva Neurosciences Inc

Chiusa

1.73 4.85

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

1.61

Massimo

1.74

Metriche Chiave

By Trading Economics

P/E

Media del settore

7.824

57.333

Dipendenti

8

Raccomandazioni

By TipRanks

Raccomandazioni

Neutrale

Previsioni per 12 mesi

+201.2% upside

Dividendi

By Dow Jones

Utili prossimi

30 apr 2025

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

-2.1M

11M

Apertura precedente

-3.12

Chiusura precedente

1.73

Minerva Neurosciences Inc Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

23 apr 2025, 23:54 UTC

Azioni calde

Stocks to Watch: International Business Machines, Southwest Airlines, Robert Half

23 apr 2025, 23:23 UTC

Notizie principali
Utili

SK Hynix Posts Strong First Quarter Earnings on AI Chip Demand

23 apr 2025, 21:06 UTC

Utili

Lam Research Notches Higher 3Q Profit and Revenue, Optimistic 4Q Outlook

23 apr 2025, 21:03 UTC

Utili

Texas Instruments Posts Increase in 1Q Sales, EPS

24 apr 2025, 00:00 UTC

Utili

Renesas Electronics 1Q Net Y26.01B Vs Net Y79.87B

24 apr 2025, 00:00 UTC

Utili

Renesas Electronics 1Q Net Y26.01B Vs Net Y79.87B

23 apr 2025, 23:47 UTC

Discorsi di Mercato

Gold Rises Amid Lingering Uncertainty Over U.S.-China Trade War -- Market Talk

23 apr 2025, 23:44 UTC

Discorsi di Mercato

Nikkei May Rise as Fears About U.S. Tariffs Ease -- Market Talk

23 apr 2025, 23:44 UTC

Discorsi di Mercato

Global Equities Roundup: Market Talk

23 apr 2025, 23:37 UTC

Discorsi di Mercato

Global Energy Roundup: Market Talk

23 apr 2025, 23:36 UTC

Discorsi di Mercato

Fed Should Have a 'High Bar' to Intervene in Markets, Hammack Says -- Market Talk

23 apr 2025, 23:21 UTC

Discorsi di Mercato

Northern Star Bull Says Share Price Accounts for Operational Risks -- Market Talk

23 apr 2025, 23:00 UTC

Notizie principali

South Korea's Economy Shrinks in 1Q Before Trump Tariffs Hit

23 apr 2025, 22:51 UTC

Utili

SK Hynix 1Q Net Profit Beat FactSet-Compiled Consensus

23 apr 2025, 22:50 UTC

Utili

SK Hynix 1Q Net KRW8.108T Vs. Net KRW1.917T >000660.SE

23 apr 2025, 22:49 UTC

Utili

SK Hynix 1Q Oper Pft KRW7.441T Vs. Pft KRW2.886T >000660.SE

23 apr 2025, 22:49 UTC

Utili

SK Hynix 1Q Rev KRW17.639T Vs. KRW12.430T >000660.SE

23 apr 2025, 22:32 UTC

Discorsi di Mercato
Acquisizioni, Fusioni, Takeovers

Global Energy Roundup: Market Talk

23 apr 2025, 22:32 UTC

Discorsi di Mercato
Acquisizioni, Fusioni, Takeovers

Woodside Appears Cornered Into 2Q Decision on Louisiana LNG -- Market Talk

23 apr 2025, 22:29 UTC

Discorsi di Mercato
Utili

ServiceNow CEO Says Aptiv Deal Marks 2nd Largest in EMEA -- Market Talk

23 apr 2025, 22:18 UTC

Utili

CGN Power: 1Q Net Weighed by Fall in Electricity Prices, Higher R&D Expenses >1816.HK

23 apr 2025, 22:17 UTC

Utili

CGN Power 1Q Net CNY3.03B Vs. Net CNY3.60B >1816.HK

23 apr 2025, 22:17 UTC

Utili

CGN Power 1Q Rev CNY20.03B Vs. CNY19.18B >1816.HK

23 apr 2025, 21:57 UTC

Discorsi di Mercato
Utili

ServiceNow Earnings, Guidance Soothe Fear of Slower Govt Business -- Market Talk

23 apr 2025, 21:48 UTC

Notizie principali

Shingles Vaccine Appears to Lower Dementia Risk -- WSJ

23 apr 2025, 21:14 UTC

Notizie principali
Utili

Southwest Airlines Drops Forecast as Leisure Travelers Pull Back -- WSJ

23 apr 2025, 21:05 UTC

Utili

Texas Instruments Reports Strong Earnings. The Stock Is Rising but Tariffs Are Still a Risk. -- Barrons.com

23 apr 2025, 21:02 UTC

Notizie principali

Huge Stock Swings Are the New Normal for Frazzled Investors -- WSJ

23 apr 2025, 20:51 UTC

Utili

Boeing Stock Surges on Earnings. There Is Still a Lot of Uncertainty Ahead. -- Barrons.com

23 apr 2025, 20:50 UTC

Discorsi di Mercato

Basic Materials Roundup: Market Talk

Confronto tra pari

Modifica del prezzo

Minerva Neurosciences Inc Previsione

Obiettivo di Prezzo

By TipRanks

201.2% in crescita

Previsioni per 12 mesi

Media 5 USD  201.2%

Alto 5 USD

Basso 5 USD

Basato su 1 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per Minerva Neurosciences Inc - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Neutrale

1 ratings

0

Acquista

1

Mantieni

0

Vendi

Notizie finanziarie

$

Chi Siamo Minerva Neurosciences Inc

Minerva Neurosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of product candidates for the treatment of central nervous system diseases. Its lead product candidate is roluperidone (MIN-101) for the treatment of negative symptoms in patients with schizophrenia, currently submitted an New Drug Application (NDA); and MIN-301, a soluble recombinant form of the neuregulin-1b1 protein for the treatment of Parkinson's disease and other neurodegenerative disorders. The company has a license agreement with Mitsubishi Tanabe Pharma Corporation to develop, sell, and import roluperidone globally excluding Asia. Minerva Neurosciences, Inc. was incorporated in 2007 and is based in Burlington, Massachusetts.